Results 161 to 170 of about 37,394 (238)

Emerging therapeutics for the treatment of light chain and transthyretin amyloidosis [PDF]

, 2019
Lenihan, Daniel J, Stockerl-Goldstein, Keith E, Zhang, Kathleen W   +2 more
core   +1 more source

Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry.

Blood, 2017
T. Kourelis, S. Dasari, J. Theis, M. Ramirez-Alvarado, Paul J. Kurtin, M. Gertz, S. Zeldenrust, Roman M. Ženka, A. Dogan, A. Dispenzieri   +9 more
semanticscholar   +1 more source

Cardiac Light Chain Deposition Disease Mimicking Immunoglobulin Light Chain Amyloidosis [PDF]

Circulation: Cardiovascular Imaging, 2020
Arata, Osanami, Toshiyuki, Yano, Genzou, Takemura, Hiroshi, Ikeda, Masafumi, Inyaku, Yuki, Toda, Naoyuki, Kamiyama, Hirohito, Sugawara, Yufu, Gocho, Takefumi, Fujito, Nobutaka, Nagano, Satoko, Takahashi, Atsuko, Muranaka, Marenao, Tanaka, Norihito, Moniwa, Kazuyuki, Murase, Kohichi, Takada, Hiroyuki, Kuroda, Yayoi, Ogawa, Tetsuji, Miura   +19 more
openaire   +2 more sources

Evaluation of Cytokine Levels in Cardiac Transthyretin and Immunoglobulin Light Chain Amyloidosis and Their Correlation with Myocardial Inflammatory Cells and MACE. [PDF]

Biomedicines
Musigk N, Suwalski P, Müller M, Violano M, Klingel K, Weiner J, Beule D, Landmesser U, Heidecker B.   +8 more
europepmc   +1 more source

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14-Year Experience of an Academic Center. [PDF]

Hematol Oncol
Dima D, Goel U, Ullah F, Faiman B, Basali D, Mazzoni S, Williams LS, Samaras C, Valent J, Anwer F, Khouri J, Raza S.   +11 more
europepmc   +1 more source

Periorbital Purpura as a Key Diagnostic Clue in Immunoglobulin Light Chain Amyloidosis. [PDF]

JMA J
Miyaue K, Isono H.
europepmc   +1 more source

Budd-Chiari Syndrome as the Presenting Feature of Systemic Immunoglobulin Light Chain Amyloidosis. [PDF]

Eur J Case Rep Intern Med
Miranda JL, Salvado C, Carmo F, Guedes A, Moreira A, Guimarães Costa T, Silva L.   +6 more
europepmc   +1 more source

Impact of the Addition of Daratumumab to the Frontline Treatment of Patients with Immunoglobulin Light-Chain Amyloidosis: A Single-Centre Experience. [PDF]

Cancers (Basel)
Alejo E, Agulló C, Puertas B, Eiros R, Rey-Búa B, Barnés C, Rodríguez-González M, López-Corral L, Santos-Briz Á, Escalante F, Pérez-García ML, Jiménez-Cabrera S, Gutiérrez NC, Puig N, Mateos MV, González-Calle V.   +15 more
europepmc   +1 more source

A mouse model of cardiac immunoglobulin light chain amyloidosis reveals insights into tissue accumulation and toxicity of amyloid fibrils. [PDF]

Nat Commun
Martinez-Rivas G, Ayala MV, Bender S, Codo GR, Swiderska WK, Lampis A, Pedroza L, Merdanovic M, Sicard P, Pinault E, Richard L, Lavatelli F, Giorgetti S, Canetti D, Rinsant A, Kaaki S, Ory C, Oblet C, Pollet J, Naser E, Carpinteiro A, Roussel M, Javaugue V, Jaccard A, Bonaud A, Delpy L, Ehrmann M, Bridoux F, Sirac C.   +28 more
europepmc   +1 more source

The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review. [PDF]

Blood Adv
Ramachandran R, Shah D, Luo C, Shah V, Cliff ERS, Sanchorawala V, Lentzsch S, Chakraborty R.   +7 more
europepmc   +1 more source